Universidade Federal do Paraná, Hospital de Clínicas, Departamento de Clínica Médica, Serviço de Neurologia, Serviço de Doenças Neuromusculares, Curitiba PR, Brazil.
Arq Neuropsiquiatr. 2023 Oct;81(10):922-933. doi: 10.1055/s-0043-1772833. Epub 2023 Oct 18.
Limb-girdle muscular dystrophy (LGMD) is a group of myopathies that lead to progressive muscle weakness, predominantly involving the shoulder and pelvic girdles; it has a heterogeneous genetic etiology, with variation in the prevalence of subtypes according to the ethnic backgrounds and geographic origins of the populations. The aim of the present study was to analyze a series of patients with autosomal recessive LGMD (LGMD-R) to contribute to a better characterization of the disease and to find the relative proportion of the different subtypes in a Southern Brazil cohort. The sample population consisted of 36 patients with LGMD-R. A 9-gene targeted next-generation sequencing panel revealed variants in 23 patients with LGMD (64%), and it identified calpainopathy (LGMD-R1) in 26%, dysferlinopathy (LGMD-R2) in 26%, sarcoglycanopathies (LGMD-R3-R5) in 13%, telethoninopathy (LGMD-R7) in 18%, dystroglicanopathy (LGMD-R9) in 13%, and anoctaminopathy (LGMD-R12) in 4% of the patients. In these 23 patients with LGMD, there were 27 different disease-related variants in the , , , , , , , and genes. There were different causal variants in different exons of these genes, except for the gene, for which all patients carried the p.Gln53* variant, and the gene, which showed recurrence of the p.Leu276Ile variant. We analyzed the phenotypic, genotypic and muscle immunohistochemical features of this Southern Brazilian cohort.
肢带型肌营养不良症(LGMD)是一组导致进行性肌肉无力的肌病,主要累及肩带和骨盆带;它具有异质性的遗传病因,根据人群的种族背景和地理起源,亚型的患病率存在差异。本研究旨在分析一组常染色体隐性遗传肢带型肌营养不良症(LGMD-R)患者,以更好地描述该疾病,并在巴西南部队列中找到不同亚型的相对比例。该样本人群包括 36 名 LGMD-R 患者。一个 9 基因靶向下一代测序小组发现 23 名 LGMD 患者(64%)存在变异,其中 26%为钙蛋白酶病(LGMD-R1),26%为肌营养不良蛋白病(LGMD-R2),13%为 sarcoglycanopathies(LGMD-R3-R5),18%为 telethoninopathy(LGMD-R7),13%为 dystroglicanopathy(LGMD-R9),4%为anoctaminopathy(LGMD-R12)。在这 23 名 LGMD 患者中,在 、 、 、 、 、 、 和 基因中发现了 27 种不同的疾病相关变异。这些基因的不同外显子中存在不同的致病变异,除了 基因,所有患者都携带 p.Gln53*变异,和 基因,其显示 p.Leu276Ile 变异的重复。我们分析了这个巴西南部队列的表型、基因型和肌肉免疫组织化学特征。